Despite mandates that determinants of health and differences in sex be incorporated into clinical trials, some groups—such as minorities, women, and those of lower socioeconomic status—are still underrepresented.
20 min.

Media coverage can be a powerful way for cardiothoracic surgeons to help more patients and their families understand important health care information. But how can you handle a reporter’s tough questions and still get your message across? Todd K. Rosengart, MD leads a panel discussion with cardiothoracic surgeons who have had experience with handling awkward media situations, connecting with a lay audience, and helping to change the course of a conversation when a reporter has incorrect information. Also features John V. Conte, MD, Robert E. Merritt, MD, Mara B. Antonoff, MD, Robbin G.

Robbin G. Cohen talks with some of the world’s leading experts in treating valve disease and endocarditis—Drs. Joseph E. Bavaria, Eric E. Roselli, and Scott Goldman—about when surgeons should get involved in the treatment process, when and how long to treat with antibiotics, the best candidates for surgery, and the ethics surrounding treating IV drug abusers.
18 min.

The Society is offering a new opportunity for self-assessment and quality improvement in cardiothoracic surgery—surgeon-specific outcomes reports from the Adult Cardiac Surgery Database (ACSD). For those who affirmatively opt in, these feedback reports will be available beginning in fall 2019 and will include data on coronary artery bypass grafting (CABG), aortic valve replacement (AVR), CABG+AVR, mitral valve repair and replacement (MVRR), and CABG+MVRR. Four STS leaders, Drs. Richard Prager, David M. Shahian, Alan M.

Some of the most successful cardiothoracic surgeons credit mentors for part of their achievements. Whether you are still in training, an early careerist, or a senior surgeon, taking part in a productive mentor/mentee arrangement has long-term benefits.

Todd K. Rosengart, MD leads a panel discussion with cardiothoracic surgeons who have had experience with handling awkward media situations, connecting with a lay audience, and helping to change the course of a conversation when a reporter has incorrect information.
18 min.

Artificial intelligence (AI) and electronic health technologies are changing how physicians conceptualize and treat diseases. Although these futuristic advancements are leading to improvements in quality, safety, and patient outcomes, these technologies also are dramatically changing the cyber threat landscape. Kevin W.

The Society is offering a new opportunity for self-assessment and quality improvement in cardiothoracic surgery—surgeon-specific outcomes reports from the Adult Cardiac Surgery Database (ACSD).
26 min.
Some of the most successful cardiothoracic surgeons credit mentors for part of their achievements. Whether you are still in training, an early careerist, or a senior surgeon, taking part in a productive mentor/mentee arrangement has long-term benefits.
17 min.
Artificial intelligence and electronic health technologies are changing how physicians conceptualize and treat diseases.
18 min.

Lung cancer morbidity and mortality remains high in the United States and beyond despite major changes over the past few years in early detection and treatment for advanced disease. Dr. Douglas E. Wood, from the University of Washington in Seattle, moderates a roundtable discussion with prominent lung cancer surgeons—Drs. Shanda H. Blackmon, Lisa M. Brown, and Mitchell J.